Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 3147 (miR-3147, MIR3147) is a small, non-coding RNA molecule classified as a microRNA[4]. MicroRNAs are involved in post-transcriptional regulation of gene expression, typically leading to mRNA degradation or translational repression[3]. miR-3147 has been described as an "oncomiR" in vulvar squamous cell carcinoma, acting via suppression of the tumor suppressor Smad4[4]. Its precise biological functions likely involve the regulation of gene networks controlling cell proliferation and tumorigenesis, but specific interacting drugs, use as a biomarker, or unique safety concerns have not been established in the available literature[4]. No evidence suggests that MIR3147 is a direct therapeutic target such as a receptor, enzyme, transporter, or similar; it is considered a regulatory non-coding RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 3147 (miR-3147).